Bollard Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-712
| Closed | -$1K | – | 277 |
|
|
2024
Q4 | $1K | Hold |
712
| – | – | ﹤0.01% | 272 |
|
|
2024
Q3 | $1K | Hold |
712
| – | – | ﹤0.01% | 290 |
|
|
2024
Q2 | $1K | Hold |
712
| – | – | ﹤0.01% | 288 |
|
|
2024
Q1 | $2K | Hold |
712
| – | – | ﹤0.01% | 283 |
|
|
2023
Q4 | $1K | Hold |
712
| – | – | ﹤0.01% | 293 |
|
|
2023
Q3 | $1K | Hold |
712
| – | – | ﹤0.01% | 339 |
|
|
2023
Q2 | $1K | Hold |
712
| – | – | ﹤0.01% | 583 |
|
|
2023
Q1 | $1K | Hold |
712
| – | – | ﹤0.01% | 276 |
|
|
2022
Q4 | $1K | Hold |
712
| – | – | ﹤0.01% | 270 |
|
|
2022
Q3 | $1K | Hold |
712
| – | – | ﹤0.01% | 275 |
|
|
2022
Q2 | $1K | Hold |
712
| – | – | ﹤0.01% | 282 |
|
|
2022
Q1 | $2K | Hold |
712
| – | – | ﹤0.01% | 422 |
|
|
2021
Q4 | $3K | Hold |
712
| – | – | ﹤0.01% | 424 |
|
|
2021
Q3 | $4K | Hold |
712
| – | – | ﹤0.01% | 416 |
|
|
2021
Q2 | $5K | Hold |
712
| – | – | ﹤0.01% | 412 |
|
|
2021
Q1 | $6K | Hold |
712
| – | – | ﹤0.01% | 418 |
|
|
2020
Q4 | $5K | Hold |
712
| – | – | ﹤0.01% | 415 |
|
|
2020
Q3 | $5K | Sell |
712
-2,246
| -76% | -$15.8K | ﹤0.01% | 418 |
|
|
2020
Q2 | $25K | Buy |
+2,958
| New | +$25K | ﹤0.01% | 401 |
|